Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

However, experts said limiting the blood test to just cholesterol misses out on catching some silent risk factors. The ...

The study authors say a blood test that examines all three biomarkers ... Women with the highest levels of lipoprotein(a) at ...

The pilot programme will see a confidential test for Lp(a) offered to 23andMe customers. If they have high levels, they can then be connected to clinicians through 23andMe’s telehealth arm ...

1 The Roche Diagnostics Tina-quant® Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein (a) in a person's bloodstream (serum and plasma), and will be broadly available ...

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

Roche Diagnostics North America president and CEO Brad Moore said: “ We are proud to support the National Lipid Association's recommendation for Lp(a) testing, emphasising accurate cardiovascular risk ...

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment of CV risk. The assay (Tina-quant Gen.2) is the first Lp(a) assay available ...

“I have five daughters, and these medicines give me hope that I might see their children grow up,” said McLaughlin, who wasn’t offered a test for Lp(a) until she was in her 60s despite ...

Fast-growing commercial-stage diagnostics company numares AG today announced the worldwide launch of its new, software-based test insightLP™-S50, part of the Company’s lipoFIT® series for lipoprotein ...

This will be the first 510(k) cleared test of its kind available in the U.S. measuring lipoprotein (a), or Lp(a), in nanomoles per liter (nmol/L). The National Lipid Association (NLA) recommends ...